njbio.com Open in urlscan Pro
141.193.213.10  Public Scan

Form analysis
1 forms found in the DOM

GET https://njbio.com/

<form role="search" method="get" class="et-search-form" action="https://njbio.com/">
  <input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:">
</form>

Text Content

 * Home
 * Services
   * Bioconjugation
   * Payloads and Linkers
   * Bioanalytical Services
   * BioNMR Services
   * Protein Degraders
   * Custom Synthesis
   * Synthesis of Nucleotides & Oligonucleotides
   * Analytical Services
   * Functional Assays
   * Service Models
   * Request a Quote
 * About Us
   * Company Profile
   * Our Team
   * Board of Directors
   * Scientific Advisory Board
 * Facilities
 * *New*
 * Resources
   * Recent Advances in ADCs
   * Payload Classes for ADCs
   * Linkers for ADCs
   * Targeted Protein Degraders
   * BioNMR for Drug Discovery
   * Application of Flow Chemistry
 * Careers
 * News and Events
 * Contact

Select Page
 * Home
 * Services
   * Bioconjugation
   * Payloads and Linkers
   * Bioanalytical Services
   * BioNMR Services
   * Protein Degraders
   * Custom Synthesis
   * Synthesis of Nucleotides & Oligonucleotides
   * Analytical Services
   * Functional Assays
   * Service Models
   * Request a Quote
 * About Us
   * Company Profile
   * Our Team
   * Board of Directors
   * Scientific Advisory Board
 * Facilities
 * *New*
 * Resources
   * Recent Advances in ADCs
   * Payload Classes for ADCs
   * Linkers for ADCs
   * Targeted Protein Degraders
   * BioNMR for Drug Discovery
   * Application of Flow Chemistry
 * Careers
 * News and Events
 * Contact


l

REQUEST A QUOTE




AFFORDABLE, TIMELY AND CUSTOMIZABLE SOLUTIONS FOR A WIDE RANGE OF DISCOVERY AND
DEVELOPMENT RESEARCH NEEDS




TESTIMONIALS

“When we were looking for a CRO with expertise in the ADC field and one that
could work closely with an early-stage company, NJ Bio stepped up to the plate
to help. They were able to meet our timelines, provide valuable insight, and
deliver several quality ADCs to evaluate in our in vitro and in vivo studies. We
will continue to utilize NJ Bio’s services as our internal ADC program continues
to mature.”

Founder and CEO, Early Stage Biotech Company



“We have worked with a number of CROs in the past, but feel we have found an
ideal, long-term partner with NJ Bio for our antibody drug conjugate activities.
NJ Bio has been open to accommodate changes beyond agreed scope to improve
quality or adapting to different needs. The expert team at NJ Bio is highly
competent and the project progress was presented and discussed on a regular
basis to achieve our goals on time.”

Director of Antibody Research, European-based Company



“I want to send you this testimonial in support of working with NJ Bio as our
main ADC CRO. Over the last 20 years of ADC work, I have worked with a large
number of different CROs in the ADC field. By far, NJ Bio has been the easiest
to work with, and the highest quality materials have been produced by their
scientists to support our programs. The scientific team at NJ Bio is top tier,
and we trust them with our most precious programs. They have successfully
produced extremely complicated custom compounds for us, and in impressive
turn-around times. Of all the CROs that we work with, we consider NJ Bio to be
our main strategic partner and actually have factored our business relationship
with them into our future growth plans.”

Director, Process Development & Technical Transfer, ADC Platform Company



“NJ Biopharma was challenged to synthesize novel phosphoramidites at the gram
scale for our company. The team quickly divided up the task and probed which
synthetic route would be scalable. With minor tweaks to each phosphoramidite,
the team completed each target in a time frame that matched our needs perfectly.
A variety of characterization was supplied including phosphorus NMR, and 2D
homonuclear spectra. We would trust further projects to be carried out by NJ
Biopharma in the future to be of similar quality and timeliness.”

Director, Large US-based Biotech Company




LATEST NEWS


NJ BIO, INC., HOSTED DR. YUTAKA MATSUDA, THE ORIGINATOR OF NOVEL AJICAP® LINKER
TECHNOLOGY FROM AJINOMOTO BIO-PHARMA SERVICES






NJ BIO, INC., HOSTED A DISCUSSION WITH THE RENOWNED RESEARCHER, DR. RAVI CHARI,
ON DEVELOPING NEXT GENERATION ADCS






NJ BIO, INC., AND AARVIK THERAPEUTICS INC. ARE EXCITED TO ANNOUNCE THEIR
COLLABORATION TO DEVELOP AND COMMERCIALISE NEXT-GENERATION ADCS FOR CANCER
THERAPY






RESOURCES

Recent Advances in ADCs

Payload Classes for ADCs

Linkers for ADCs

Targeted Protein Degraders

BioNMR for Drug Discovery

Application of Flow Chemistry

v

CALL NJ BIO

732-202-5664



EMAIL NJ BIO

info@njbio.com


NJ BIO HEADQUARTERS

350 Carter Rd
Princeton, NJ 08540


OUR BRISTOL FACILITY

310 George Patterson Boulevard,
Bristol, PA 19007


QUICK LINKS

HOME

ABOUT US

FACILITIES

CAREERS

NEWS AND EVENTS

CONTACT US / REQUEST QUOTE


SCIENCE EXCHANGE



© 2019 NJ Bio, Inc.

 * Follow
 * Follow
 * Follow
 * Follow
 * Follow